<table border="single" id="id_d39224f2-922d-49d4-996c-d93a4b7a3256" width="657.000" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption id="id_deb36c62-beac-42ce-a17a-96eaf0b278d9">Table 9. Pharmacokinetic Parameters of Voriconazole in Patients at Risk for Aspergillosis</caption>
<col width="33.8%"></col>
<col width="33.8%"></col>
<col width="32.4%"></col>
<tbody>
<tr id="id_9aef28b6-4ebf-4e9c-8c5d-fea88786eaa6">
<td align="left" stylecode="Botrule Toprule Rrule Lrule" valign="top"></td>
<td align="center" stylecode="Botrule Rrule" valign="top">
<paragraph>200 mg Oral q12h</paragraph>(n = 9) </td>
<td align="center" stylecode="Botrule Rrule" valign="top">
<paragraph>300 mg Oral q12h</paragraph>(n = 9) </td>
</tr>
<tr id="id_500e2ee4-11ad-4c76-bc03-317dabdab284">
<td align="left" stylecode="Lrule Botrule Rrule" valign="top">
<paragraph>AUCτ <footnote id="id-d259f3d5-51e9-407e-baa2-cde719a6b9f1">Geometric mean values on Day 14 of multiple dosing in two cohorts of patients</footnote> (mcg•h/mL)</paragraph>(CV%) </td>
<td align="center" stylecode="Botrule Rrule" valign="top">
<paragraph>20.31</paragraph>(69%)</td>
<td align="center" stylecode="Botrule Rrule" valign="top">
<paragraph>36.51</paragraph>(45%)</td>
</tr>
<tr id="id_ae6f7964-bf12-4d2e-b7a7-ce8754eb9177">
<td align="left" stylecode="Lrule Botrule Rrule" valign="top">
<paragraph>Cmax <footnoteref idref="id-d259f3d5-51e9-407e-baa2-cde719a6b9f1"></footnoteref> (mcg/mL)</paragraph>(CV%) </td>
<td align="center" stylecode="Rrule" valign="top">
<paragraph>3</paragraph>(51%)</td>
<td align="center" stylecode="Botrule Rrule" valign="top">
<paragraph>4.66</paragraph>(35%)</td>
</tr>
</tbody>
</table>